Home
Research Areas
Research Locations
Programs
PUBLICATIONS /
resources
About
Media center
Events
search
Contribute

 

      Population Council > Population Council Licensing Opportunities

POPULATION COUNCIL LICENSING OPPORTUNITIES

The Population Council seeks to improve the family planning and reproductive health options of people throughout the world. To further this end, the Council develops and evaluates promising ideas for new reproductive health products. The Council conducts fundamental research on reproductive and immunological processes, which serves as the basis for the development of new contraceptive methods, hormone therapies, and AIDS-prevention products. The Council's Intellectual Asset Management group engages development and licensing partners, leading to the commercial manufacture and marketing of finished products.

Term sheet
Click here to view a generic term sheet describing the general provisions that would typically be included in any license/joint development agreement with the Population Council along with customary representations and warranties and other provisions.

Registered products

Jadelle®: NDA 20-544/S-003

  • Two-rod subdermal implant for contraception (more)

  • FDA approval

    1. Approved labeling (PDF)

    2. Letter from the FDA to the Council documenting extension of the approved duration of use for the prevention of pregnancy from “up to 3 years” to “up to 5 years” (offsite PDF)

  • Monograph summarizing scientific data and lessons learned about marketing (PDF)

  • Available to license for marketing in the United States

Nestorone® implant

  • Single-rod subdermal implant for female contraception and hormone replacement (more)

  • Approved in Brazil

  • Phase 2 studies completed

  • Patent protection through 2015 (offsite full text 1; offsite full text 2)

  • Available for licensing worldwide

Progering® and Fertiring®

  • Progesterone vaginal ring for contraception during lactation and hormone supplementation for in vitro fertilization programs (more)

  • Approved in Chile and Peru (PDF)

  • Publications providing more details about the progesterone vaginal ring (more)

  • Patent protection through 2016 (offsite full text)

  • Available for licensing outside South America

Products in clinical trials

Nestorone®/ethinyl estradiol ring

[Gln']-luteinizing hormone-releasing hormone conjugate of tetanus vaccine and its uses

  • Phase 1 trial ongoing (more)

  • Patent protection through 2011 (offsite full text)

  • Available for licensing worldwide

Patented products

Transdermal Nestorone® (more)

Nestorone® patch

Nestorone® gel

  • Patent protection through 2014 (offsite full text)

  • Available for licensing worldwide

Lonidamine

  • Indazole derivatives (more)

  • Early basic research

  • Patent protection through 2019 (offsite full text)

  • Available for licensing worldwide

Other patents and patent applications

Carraguard®

  • Vaginal microbicide for protection against HIV transmission (more)

  • Phase 3 trials completed (offsite full text)

  • Patent application filed in 2002 (offsite full text)

  • Available for licensing worldwide

Occludin

  • Male contraception

  • Early basic research

  • Patent application filed in 2001 (offsite full text)

  • Available for licensing worldwide

Peptide nucleic acids

  • Targeted drug delivery

  • Early basic research

  • Patent application filed in 2001 (offsite full text)

  • Available for licensing worldwide

Isolated DNA molecule encoding SPRM-1 protein

  • Patent protection through 2014 (offsite full text)

  • Available for licensing worldwide

Leydig cell stimulator

  • Patent protection through 2011 (offsite full text)

  • Available for licensing worldwide

Please register and describe your interest here.


Print this page

@
E-mail this page

This page updated
19 August 2008